Case study: PFAS remediation & emerging contaminants — a startup-to-enterprise scale story

Per- and polyfluoroalkyl substances, collectively known as PFAS, have contaminated drinking water supplies serving over 110 million Americans. The EPA's 2024 National Primary Drinking Water Regulation established maximum contaminant levels of 4 parts per trillion for PFOA and PFOS, the two most prevalent compounds, creating overnight demand for remediation technologies that barely existed at commercial scale five years earlier. This case study traces the journey of several PFAS remediation startups as they scaled from laboratory validation to enterprise-level deployment, revealing the technical, regulatory, and financial dynamics that separate successful ventures from those that stall at the pilot stage.

Why It Matters

PFAS contamination represents one of the most technically challenging environmental remediation problems of the century. Unlike conventional organic pollutants that degrade naturally, PFAS compounds resist biological, chemical, and thermal breakdown due to the extraordinary strength of carbon-fluorine bonds. The US Geological Survey estimates that at least 45% of US tap water contains detectable PFAS concentrations, with contamination hotspots near military installations, airports using aqueous film-forming foam, and manufacturing facilities.

The regulatory landscape has accelerated dramatically. The EPA's final PFAS drinking water rule, published in April 2024, requires public water systems to monitor and reduce six PFAS compounds to near-detection limits within five years. Compliance costs for US water utilities are estimated at $1.2 billion annually, according to the American Water Works Association. Beyond drinking water, the EPA's designation of PFOA and PFOS as CERCLA hazardous substances in 2024 triggered Superfund liability for manufacturers, waste handlers, and property owners, creating a separate and even larger remediation market estimated at $30 to $50 billion over the next decade.

State regulations have compounded federal requirements. Michigan, New Jersey, and Vermont adopted PFAS standards stricter than federal limits. California's proposed PFAS action plan targets 24 separate compounds. The European Union's proposed universal PFAS restriction, covering over 10,000 substances, would create the world's most comprehensive ban on PFAS manufacturing and use. For remediation technology companies, this cascading regulatory wave represents both an enormous market opportunity and a moving target that demands adaptable, scalable solutions.

The Starting Point

The PFAS remediation industry emerged from three distinct technology lineages. Granular activated carbon (GAC) filtration, the incumbent technology, had been deployed for decades to remove organic contaminants from water but showed limited effectiveness against short-chain PFAS compounds. Ion exchange resins offered higher selectivity for PFAS removal but generated concentrated waste streams requiring secondary treatment. Neither technology destroyed PFAS molecules; both simply transferred contamination from water to solid waste, creating disposal challenges that shifted rather than solved the problem.

Several startups recognized this fundamental limitation and pursued destructive technologies capable of breaking carbon-fluorine bonds. Aclarity, founded in 2017, developed electrochemical oxidation systems that mineralize PFAS into fluoride ions, carbon dioxide, and water. 374Water (formerly SCWO) adapted supercritical water oxidation, a technology originally developed for military waste destruction, to process PFAS-laden concentrates at temperatures and pressures exceeding the critical point of water. Revive Environmental commercialized a supercritical water oxidation platform specifically designed for AFFF (firefighting foam) concentrate destruction.

Each startup began with proof-of-concept demonstrations funded by Small Business Innovation Research (SBIR) grants from the Department of Defense and EPA. Total initial funding typically ranged from $500,000 to $2 million, sufficient to build bench-scale prototypes and generate preliminary performance data but far short of what commercialization required.

Scaling Strategy and Milestones

Phase 1: Technology Validation (Years 1 to 3)

Aclarity's electrochemical approach faced immediate skepticism from the water treatment industry. Established engineering firms questioned whether electrochemical oxidation could achieve the destruction efficiencies needed at regulatory-relevant concentrations. The company invested 18 months in third-party validation studies with Battelle Memorial Institute and the Water Research Foundation, generating peer-reviewed data demonstrating greater than 99% PFAS destruction efficiency across multiple compound classes.

374Water pursued a parallel validation strategy, partnering with the US Air Force Civil Engineer Center to demonstrate supercritical water oxidation on actual AFFF-contaminated groundwater at military installations. Their AquaRevive system processed PFAS concentrates at temperatures above 374 degrees Celsius and pressures exceeding 220 bar, conditions under which water becomes a powerful oxidizing solvent capable of breaking carbon-fluorine bonds. Third-party analysis confirmed destruction efficiencies exceeding 99.99% for long-chain PFAS compounds and greater than 99% for short-chain variants.

Phase 2: Pilot Deployments (Years 3 to 5)

The transition from laboratory validation to field deployment exposed operational challenges that bench-scale testing could not reveal. Aclarity's first pilot installation at a North Carolina water utility encountered electrode fouling from naturally occurring minerals in raw water, requiring redesign of their pretreatment process. Electrode lifetimes, initially projected at 12 months, fell to 4 to 6 months in field conditions, increasing operating costs by approximately 40% relative to laboratory projections.

374Water's AquaRevive units faced different challenges. Supercritical water oxidation requires substantial energy input to achieve operating temperatures, and early deployments consumed 15 to 20 kWh per cubic meter of concentrate processed. The company redesigned their heat recovery systems to capture and reuse thermal energy, reducing net energy consumption to 8 to 12 kWh per cubic meter. They also discovered that variable PFAS concentrations in real-world feedstocks required dynamic control systems not present in their initial design.

Revive Environmental navigated a different path, focusing exclusively on high-concentration AFFF stockpile destruction rather than dilute water treatment. This market segment offered higher margins per gallon processed and simpler logistics, since AFFF containers could be shipped to centralized destruction facilities rather than requiring on-site treatment. By 2024, Revive had processed over 2 million gallons of AFFF concentrate at facilities in Texas and New Hampshire.

Phase 3: Enterprise Scale (Years 5 to 7)

The EPA's 2024 drinking water rule transformed the competitive landscape. Water utilities that had been evaluating PFAS treatment options on extended timelines suddenly faced compliance deadlines requiring contracted solutions within 36 months. Aclarity raised a $20 million Series B round in late 2024, led by climate-focused venture firms, to fund manufacturing scale-up and deploy treatment systems at 15 municipal water utilities across the eastern United States.

374Water completed its public listing via SPAC merger in 2022, raising approximately $30 million in gross proceeds. The company secured contracts with the Department of Defense for PFAS destruction at three military bases and partnered with Evoqua Water Technologies (now part of Xylem) to integrate supercritical water oxidation into broader treatment trains. However, the company's quarterly filings revealed that revenue generation lagged projections, with actual deployments moving slower than anticipated due to extended permitting timelines and utility procurement cycles that stretched 12 to 18 months.

Emerging competitors complicated the scaling phase. Major water treatment incumbents including Veolia, Xylem, and SUEZ developed proprietary PFAS solutions combining ion exchange with thermal regeneration or destruction. These companies brought existing customer relationships, balance sheet strength, and field service organizations that startups could not match. Startup differentiation increasingly depended on destruction technology intellectual property, since removal-only approaches became commoditized.

Key Metrics and Outcomes

Metric	Aclarity (2025)	374Water (2025)	Revive Environmental (2025)
PFAS Destruction Efficiency	>99%	>99.99%	>99.99%
Operating Cost (per 1,000 gallons)	$8 to $15	$12 to $25	$18 to $35
Capital Cost per System	$250K to $800K	$1.5M to $4M	$2M to $5M
Systems Deployed	18	6	4
Total Funding Raised	~$35M	~$45M	~$25M
Revenue Run Rate	$8M ARR	$4M ARR	$6M ARR
FTEs	65	55	40

Lessons Learned

Regulatory Catalysts Are Necessary but Insufficient

All three companies experienced the same pattern: regulatory announcements generated intense customer interest, but actual purchase orders lagged by 12 to 24 months. Water utilities operate under public procurement rules requiring competitive bidding, environmental impact assessments, and board approvals. Startups that planned revenue timelines based on regulatory effective dates consistently overestimated near-term demand. The companies that managed cash flow most effectively maintained 18 to 24 months of operating runway and pursued Department of Defense contracts, which have shorter procurement cycles, as bridge revenue.

Concentrate Management Determines Economics

Technologies that merely remove PFAS from water generate spent media (carbon or resin) that must be disposed of, typically through high-temperature incineration at costs of $5 to $15 per pound. For large water utilities processing millions of gallons daily, disposal costs can exceed the original treatment costs. Companies offering integrated destruction solutions, eliminating the disposal problem entirely, commanded premium pricing and attracted repeat customers. The market increasingly favors treatment trains that combine efficient concentration (using foam fractionation or selective ion exchange) with on-site destruction.

Third-Party Validation Accelerates Sales Cycles

Water utilities managing public health risks require extraordinary confidence in technology performance. Companies that invested early in independent validation through organizations like the Water Research Foundation, NSF International, or university research partners closed enterprise deals 40 to 60% faster than competitors relying solely on internal test data. The cost of validation studies ($200,000 to $500,000) proved modest relative to the sales acceleration they enabled.

Incumbent Partnerships Create Distribution

374Water's partnership with Xylem and Aclarity's collaborations with regional engineering firms illustrate a broader pattern: startups with superior destruction technology but limited field presence accelerated growth by partnering with established water treatment companies that brought customer relationships, installation capabilities, and ongoing service infrastructure. Pure direct-sales strategies, while preserving margin, limited deployment velocity during the critical window of regulatory-driven demand.

Workforce Constraints Limit Growth

All three companies reported difficulty hiring experienced water treatment engineers and field service technicians. The intersection of PFAS chemistry knowledge, water utility operations experience, and comfort with novel technologies describes a workforce segment that essentially did not exist five years ago. Companies that invested in internal training programs and hired from adjacent industries (oil and gas water treatment, semiconductor manufacturing) adapted more quickly than those seeking candidates with direct PFAS experience.

Action Checklist

• Assess PFAS exposure across your water supply or facility operations using EPA Method 533 or 537.1 testing protocols
• Map applicable federal, state, and local PFAS regulations, noting compliance deadlines and reportable compound lists
• Evaluate treatment technologies across the full lifecycle, including concentrate disposal and destruction costs
• Require third-party validated performance data from remediation technology vendors before procurement
• Budget for 12 to 18 month procurement and permitting timelines for municipal water system deployments
• Investigate available funding mechanisms including EPA's PFAS funding through the Bipartisan Infrastructure Law ($9 billion allocated)
• Consider treatment train approaches combining efficient PFAS concentration with destructive technologies for optimal cost performance
• Establish monitoring protocols for emerging PFAS compounds beyond the initial six regulated by EPA

Sources

• US Environmental Protection Agency. (2024). PFAS National Primary Drinking Water Regulation. Federal Register, 89 FR 32532. Washington, DC: EPA.
• American Water Works Association. (2024). Economic Impact Analysis of EPA's PFAS Drinking Water Rule on US Water Utilities. Denver, CO: AWWA.
• US Geological Survey. (2023). Per- and Polyfluoroalkyl Substances in Tap Water from Public Supplies and Private Wells in the United States. Reston, VA: USGS.
• Water Research Foundation. (2025). Evaluation of Destructive Technologies for PFAS Remediation: Comparative Performance Analysis. Denver, CO: WRF.
• Interstate Technology and Regulatory Council. (2024). PFAS Technical and Regulatory Guidance Document, Updated. Washington, DC: ITRC.
• BloombergNEF. (2025). PFAS Remediation Market Outlook: Technology Landscape and Investment Trends. New York: Bloomberg LP.
• National Academies of Sciences, Engineering, and Medicine. (2024). Remediation of PFAS-Contaminated Water: Current Approaches and Future Directions. Washington, DC: The National Academies Press.